Over the years, experts have tried their best to do their research and experiments to know more about cancer and how to alter the disease. Amid all those doctors and scientists, there is but one Biopharmaceutical Company who claimed they would already be able to discover a drug that can be used as the very first cure to all kinds of cancer by next year.
Dan Aridor, chairman of the board for Accelerated Evolution Biotechnologies (AEBi), which is a biopharmaceutical company in Israel, said, "We believe we will offer in a year's time a complete cure for cancer."
The Israeli Chairman assured that the cancer cure they will about to release will be very effective and will create astonishing results the very first-time patients take it, according to Intermountain Jewish News. He further explained that their treatment would have little to no negative side-effects in the body, so the patients don't need to worry as they consume it.
"Our solution will be more generic and personal," Aridor added.
The team of researchers of the AEBi was able to come up with this output after working on their research for more than a decade, though the team revealed that it was just four years ago that they had focused more on the "generic and personal solutions for cancer".
The AEBi's way to achieve this is by using a new technique, which they have called "functional phage display." This technique will eventually help the body produce a specific protein known as "therapeutic peptides."
Science explains that during a phage display, bacteria, which are called phages, were infected by viruses. During the process, its cellular machinery is altered, which makes it more like a virus.
Through this process, experts were able to copy the program and insert foreign genetic material into these phages, alongside the viruses, to create, spread and propagate the medicine.
The news brought new hope not just to the Israeli people but also to the people around the globe especially those who are suffering from the deadly illness.
But unfortunately, some experts seem not to be so convinced about their promise, as reported by WSB- TV 2 Atlanta.
Vince C. Luca, Ph.D., principal investigator in drug discovery at the Moffitt Cancer Center said, "There are over 200 human cancers" recorded at present, among all these kinds "finding a cure for even one or two would be a major accomplishment. Claiming to cure them all is impossible."
A representative of the AEBi clarifies the statement saying their company won't release the medicine to the market after a year yet. What they just promised is that the team is planning to try the treatment on people by then.
